{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:52:01Z","timestamp":1778626321295,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T00:00:00Z","timestamp":1558656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010727","name":"Axel Muusfeldts Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004954","name":"Augustinus Fonden","doi-asserted-by":"publisher","award":["17-1151"],"award-info":[{"award-number":["17-1151"]}],"id":[{"id":"10.13039\/501100004954","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Magda Sofie og Aase L\u00fctz's Mindelegat Fond"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1924-1","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:03:22Z","timestamp":1558699402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Virus-like vaccines against HIV\/SIV synergize with a subdominant antigen T cell vaccine"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8193-3328","authenticated-orcid":false,"given":"Melanie","family":"Schwerdtfeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie Carola","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse","family":"Neukirch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Johannes","family":"Holst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,24]]},"reference":[{"key":"1924_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nature07352","volume":"455","author":"DH Barouch","year":"2008","unstructured":"Barouch DH. Challenges in the development of an HIV-1 vaccine. Nature. 2008;455:613\u20139. \n                    https:\/\/doi.org\/10.1038\/nature07352\n                    \n                  .","journal-title":"Nature"},{"key":"1924_CR2","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med. 2009;361:2209\u201320. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0908492\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1924_CR3","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. 2012;366:1275\u201386. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1113425\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1924_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm1520","volume":"13","author":"P Kiepiela","year":"2007","unstructured":"Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med. 2007;13:46\u201353. \n                    https:\/\/doi.org\/10.1038\/nm1520\n                    \n                  .","journal-title":"Nat Med"},{"key":"1924_CR5","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.1128\/JVI.02689-06","volume":"81","author":"I Honeyborne","year":"2007","unstructured":"Honeyborne I, Prendergast A, Pereyra F, Leslie A, Crawford H, Payne R, et al. Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8+ T-cell epitopes. J Virol. 2007;81:3667\u201372. \n                    https:\/\/doi.org\/10.1128\/JVI.02689-06\n                    \n                  .","journal-title":"J Virol"},{"key":"1924_CR6","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1371\/journal.ppat.0030157","volume":"3","author":"M Rolland","year":"2007","unstructured":"Rolland M, Nickle DC, Mullins JI. HIV-1 group M conserved elements vaccine. PLoS Pathog. 2007;3:e157. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.0030157\n                    \n                  .","journal-title":"PLoS Pathog"},{"key":"1924_CR7","doi-asserted-by":"publisher","first-page":"e60245","DOI":"10.1371\/journal.pone.0060245","volume":"8","author":"V Kulkarni","year":"2013","unstructured":"Kulkarni V, Rosati M, Valentin A, Ganneru B, Singh AK, Yan J, et al. HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice. PLoS ONE. 2013;8:e60245. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0060245\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"1924_CR8","doi-asserted-by":"publisher","first-page":"e86254","DOI":"10.1371\/journal.pone.0086254","volume":"9","author":"V Kulkarni","year":"2014","unstructured":"Kulkarni V, Valentin A, Rosati M, Alicea C, Singh AK, Jalah R, et al. Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques. PLoS ONE. 2014;9:e86254. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0086254\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"1924_CR9","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.4049\/jimmunol.1600697","volume":"197","author":"X Hu","year":"2016","unstructured":"Hu X, Valentin A, Dayton F, Kulkarni V, Alicea C, Rosati M, et al. DNA prime-boost vaccine regimen to increase breadth, magnitude, and cytotoxicity of the cellular immune responses to subdominant gag epitopes of simian immunodeficiency virus and HIV. J Immunol. 2016;197:3999\u20134013. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1600697\n                    \n                  .","journal-title":"J Immunol."},{"key":"1924_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1489949","author":"X Hu","year":"2018","unstructured":"Hu X, Lu Z, Valentin A, Rosati M, Broderick KE, Sardesai NY, et al. Gag and env conserved element CE DNA vaccines elicit broad cytotoxic T cell responses targeting subdominant epitopes of HIV and SIV Able to recognize virus-infected cells in macaques. Hum Vaccin Immunother. 2018. \n                    https:\/\/doi.org\/10.1080\/21645515.2018.1489949\n                    \n                  .","journal-title":"Hum Vaccin Immunother."},{"key":"1924_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12967-016-1102-7","volume":"14","author":"AMC Andersson","year":"2016","unstructured":"Andersson AMC, Holst PJ. Increased T cell breadth and antibody response elicited in prime-boost regimen by viral vector encoded homologous SIV Gag\/Env in outbred CD1 mice. J Transl Med. 2016;14:343. \n                    https:\/\/doi.org\/10.1186\/s12967-016-1102-7\n                    \n                  .","journal-title":"J Transl Med."},{"key":"1924_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature10766","volume":"482","author":"DH Barouch","year":"2012","unstructured":"Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, et al. Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature. 2012;482:89\u201393. \n                    https:\/\/doi.org\/10.1038\/nature10766\n                    \n                  .","journal-title":"Nature"},{"key":"1924_CR13","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1126\/science.aab3886","volume":"349","author":"DH Barouch","year":"2015","unstructured":"Barouch DH, Alter G, Broge T, Linde C, Ackerman ME, Brown EP, et al. Protective efficacy of adenovirus\/protein vaccines against SIV challenges in rhesus monkeys. Science. 2015;349:320\u20134. \n                    https:\/\/doi.org\/10.1126\/science.aab3886\n                    \n                  .","journal-title":"Science"},{"key":"1924_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1742-4690-10-117","volume":"10","author":"G Nabi","year":"2013","unstructured":"Nabi G, GenanntBonsmann MS, Tenbusch M, Gardt O, Barouch DH, Temchura V, Uberla K. GagPol-specific CD4+ T-cells increase the antibody response to Env by intrastructural help. Retrovirology. 2013;10:117. \n                    https:\/\/doi.org\/10.1186\/1742-4690-10-117\n                    \n                  .","journal-title":"Retrovirology."},{"key":"1924_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ebiom.2017.03.003","volume":"18","author":"H Xu","year":"2017","unstructured":"Xu H, Andersson A-M, Ragonnaud E, Boilesen D, Tolver A, Jensen BAH, et al. Mucosal vaccination with heterologous viral vectored vaccine targeting subdominant SIV accessory antigens strongly inhibits early viral replication. EBioMedicine. 2017;18:204\u201315. \n                    https:\/\/doi.org\/10.1016\/j.ebiom.2017.03.003\n                    \n                  .","journal-title":"EBioMedicine."},{"key":"1924_CR16","doi-asserted-by":"publisher","first-page":"e0117242","DOI":"10.1371\/journal.pone.0117242","volume":"10","author":"PJ Holst","year":"2015","unstructured":"Holst PJ, Jensen BAH, Ragonnaud E, Thomsen AR, Christensen JP. Targeting of non-dominant antigens as a vaccine strategy to broaden T-cell responses during chronic viral infection. PLoS ONE. 2015;10:e0117242. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0117242\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"1924_CR17","doi-asserted-by":"publisher","first-page":"e1006529","DOI":"10.1371\/journal.ppat.1006529","volume":"13","author":"MA Martins","year":"2017","unstructured":"Martins MA, Shin YC, Gonzalez-Nieto L, Domingues A, Gutman MJ, Maxwell HS, et al. Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques. PLoSPathog. 2017;13:e1006529. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1006529\n                    \n                  .","journal-title":"PLoSPathog."},{"key":"1924_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4049\/jimmunol.176.1.85","volume":"176","author":"Z Hel","year":"2006","unstructured":"Hel Z, Tsai W-P, Tryniszewska E, Nacsa J, Markham PD, Lewis MG, et al. Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes. J Immunol. 2006;176:85\u201396. \n                    https:\/\/doi.org\/10.4049\/jimmunol.176.1.85\n                    \n                  .","journal-title":"J Immunol."},{"key":"1924_CR19","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.4049\/jimmunol.1000751","volume":"185","author":"S Kannanganat","year":"2010","unstructured":"Kannanganat S, Nigam P, Velu V, Earl PL, Lai L, Chennareddi L, et al. Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA\/MVA vaccine. J Immunol. 2010;185:7262\u201373. \n                    https:\/\/doi.org\/10.4049\/jimmunol.1000751\n                    \n                  .","journal-title":"J Immunol"},{"issue":"Pt A","key":"1924_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0091-679X(08)60603-2","volume":"43","author":"TC Becker","year":"1994","unstructured":"Becker TC, Noel RJ, Coats WS, G\u00f3mez-Foix AM, Alam T, Gerard RD, Newgard CB. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 1994;43(Pt A):161\u201389.","journal-title":"Methods Cell Biol."},{"key":"1924_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1385\/1-59259-789-0:077","volume":"269","author":"C Staib","year":"2004","unstructured":"Staib C, Drexler I, Sutter G. Construction and isolation of recombinant MVA. Methods Mol Biol. 2004;269:77\u2013100. \n                    https:\/\/doi.org\/10.1385\/1-59259-789-0:077\n                    \n                  .","journal-title":"Methods Mol Biol"},{"key":"1924_CR22","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1016\/j.vaccine.2016.08.089","volume":"34","author":"AMC Andersson","year":"2016","unstructured":"Andersson AMC, Ragonnaud E, Seaton KE, Sawant S, Folgori A, Colloca S, et al. Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations. Vaccine. 2016;34:5344\u201351. \n                    https:\/\/doi.org\/10.1016\/j.vaccine.2016.08.089\n                    \n                  .","journal-title":"Vaccine."},{"key":"1924_CR23","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.4049\/jimmunol.0903894","volume":"185","author":"M Grujic","year":"2010","unstructured":"Grujic M, Bartholdy C, Remy M, Pinschewer DD, Christensen JP, Thomsen AR. The role of CD80\/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus. J Immunol. 2010;185:1730\u201343. \n                    https:\/\/doi.org\/10.4049\/jimmunol.0903894\n                    \n                  .","journal-title":"J Immunol."},{"key":"1924_CR24","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1128\/JVI.00465-13","volume":"87","author":"MA Steffensen","year":"2013","unstructured":"Steffensen MA, Holst PJ, Steengaard SS, Jensen BAH, Bartholdy C, Stryhn A, et al. Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation. J Virol. 2013;87:6283\u201395. \n                    https:\/\/doi.org\/10.1128\/JVI.00465-13\n                    \n                  .","journal-title":"J Virol"},{"key":"1924_CR25","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/mt.2014.15","volume":"22","author":"S Capone","year":"2014","unstructured":"Capone S, Naddeo M, D\u2019Alise AM, Abbate A, Grazioli F, Del Gaudio A, et al. Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates. Mol Ther. 2014;22:1039\u201347. \n                    https:\/\/doi.org\/10.1038\/mt.2014.15\n                    \n                  .","journal-title":"Mol Ther"},{"key":"1924_CR26","doi-asserted-by":"publisher","first-page":"9579","DOI":"10.1128\/JVI.00975-14","volume":"88","author":"S Kwa","year":"2014","unstructured":"Kwa S, Lai L, Gangadhara S, Siddiqui M, Pillai VB, Labranche C, et al. CD40L-adjuvanted DNA\/modified vaccinia virus Ankara simian immunodeficiency virus SIV239 vaccine enhances SIV-specific humoral and cellular immunity and improves protection against a heterologous SIVE660 mucosal challenge. J Virol. 2014;88:9579\u201389. \n                    https:\/\/doi.org\/10.1128\/JVI.00975-14\n                    \n                  .","journal-title":"J Virol"},{"key":"1924_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.virol.2009.07.041","volume":"394","author":"F Gao","year":"2009","unstructured":"Gao F, Scearce RM, Alam SM, Hora B, Xia S, Hohm JE, et al. Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins. Virology. 2009;394:91\u20138. \n                    https:\/\/doi.org\/10.1016\/j.virol.2009.07.041\n                    \n                  .","journal-title":"Virology"},{"key":"1924_CR28","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.1128\/JVI.00996-12","volume":"86","author":"KE Stephenson","year":"2012","unstructured":"Stephenson KE, Li H, Walker BD, Michael NL, Barouch DH. Gag-specific cellular immunity determines in vitro viral inhibition and in vivo virologic control following simian immunodeficiency virus challenges of vaccinated rhesus monkeys. J Virol. 2012;86:9583\u20139. \n                    https:\/\/doi.org\/10.1128\/JVI.00996-12\n                    \n                  .","journal-title":"J Virol"},{"key":"1924_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/icb.2016.65","volume":"94","author":"AM Collins","year":"2016","unstructured":"Collins AM. IgG subclass co-expression brings harmony to the quartet model of murine IgG function. Immunol Cell Biol. 2016;94:949\u201354. \n                    https:\/\/doi.org\/10.1038\/icb.2016.65\n                    \n                  .","journal-title":"Immunol Cell Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1924-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1924-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1924-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T23:12:06Z","timestamp":1590189126000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1924-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1924"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1924-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,24]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The animal studies have been approved by the Danish national oversight committee on the experimentation on animals (ref. ID: 2016-15-0201-01131) and relies exclusively on purpose bred experimental animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"PJH is an inventor on a manuscript-related patent (published as WO2007062656) and a founder and shareholder of InProTher\u00a0ApS, a biotech company which holds a license to use the invariant chain sequence for vaccination purposes against certain indications including HIV. ACA became an employee of InProTher between submission and acceptance of the manuscript.MS and LN declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"175"}}